139859-Thumbnail Image.png
Description

The FDA-approved drug bexarotene has been predominantly utilized for the treatment of cutaneous T-cell lymphoma (CTLC), but has shown promise as an off label treatment for various other cancers as well as Alzheimer's disease (AD).

3.11 MB application/pdf

Download restricted. Please sign in.

Download count: 0

Details

Contributors
Date Created
2016-05
Resource Type
  • Text
  • Machine-readable links